Olink

Olink®
Part of Thermo Fisher Scientific

Scientific publications

Discover the latest research using Olink’s panels for protein biomarker discovery through our comprehensive list of publications. Easily find relevant studies by filtering them or using the free-text search.  Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Filter

Filters

Publication
Disease Area
Application Area
Sample Type
Products

International Journal of Molecular Sciences, 2025

Mediating Role of the ANGPTL3/TFPI Protein Ratio in Regulating T-Cell Surface Glycoprotein CD5 Levels on Knee Osteoarthritis (KOA): A Mendelian Randomization Study

Li Y., Liao X., Yu X. et al.

Journal of Proteome Research, 2025

Plasma Proteomics-Based Identification of Novel Predictive and Diagnostic Inflammatory Biomarkers for Diabetic Foot

Feng Y., Jiang B., Luo Q. et al.

Therapeutic Advances in Endocrinology and Metabolism, 2025

Multi-omics investigation of prospective therapeutic targets for type 1 diabetes

Zhang Y., Qiao Q., Chen B. et al.

Molecular Neurobiology, 2025

Identifying Immune Response Protein Biomarkers in Parkinson’s-Related Cognitive Impairment and Depression

Su Q., Lu T., Xu Y. et al.

Journal of Inflammation Research, 2025

Shared and Distinctive Inflammation-Related Protein Profiling in Idiopathic Inflammatory Myopathy with/without Anti-MDA5 Autoantibodies

Zhang Y., Hu W., Li T. et al.

Cardiovascular Research, 2025

Plasma proteomic and metabolomic profiling of coronary and carotid atherosclerosis in the SCAPIS study—differences and similarities

Fall T., Gummesson A., Hammar U. et al.

International Journal of Molecular Sciences, 2025

Unraveling the COVID-19 Severity Hubs and Interplays in Inflammatory-Related RNA–Protein Networks

Park H., Wang Q., Hasegawa T. et al.

The Journal of Dermatology, 2025

Immunoproteomic Response to IL‐17A Blockade in a Patient With Generalized Pustular Psoriasis: New Insights From Plasma Olink Profiling

Jeng Y., Liao Y., Hong Y. et al.

Journal of Cardiology, 2025

Causal relationship between circulating inflammatory proteins and atherosclerosis: a bidirectional Mendelian randomization study and meta-analysis

Xu B., Xu Q., Wang Y. et al.

Molecular Neurobiology, 2025

Uncovering Potential Susceptibility Genes for Multiple Sclerosis-Induced Neuropathic Bladder: A Mendelian Randomization Analysis

Xu Y., Xiong J., Wu Y. et al.

The Journal of Nutrition, 2025

Metabolomic and Proteomic Signatures of Ultra-processed Foods Are Positively Associated with Adverse Liver Outcomes

Zhao L., Chen Y., Clay-Gilmour A. et al.

Journal of the American College of Cardiology, 2025

Effect of Empagliflozin on the Mechanisms Driving Erythropoiesis and Iron Mobilization in Patients With Heart Failure

Ferreira J., Anker S., Butler J. et al.

BMC Pregnancy and Childbirth, 2025

Sleeping for two: a cross-sectional study on associations between objectively measured sleep during early to mid-pregnancy and maternal and fetal outcomes and inflammatory biomarker profiles

Macdonald C., Pitsillos T., Wikström A. et al.

International Immunopharmacology, 2025

The interplay between systemic inflammation and myopia: A bidirectional Mendelian randomization and experimental validation study

Huang Z., Zhou J., Liu S. et al.

Journal of Advanced Research, 2025

Plasma proteomics identify novel biomarkers and dynamic patterns of biological aging

Ma L., Liu W., He Y. et al.

Discover Oncology, 2025

Integrating analysis of multi-omics summary data identifies novel plasma protein biomarkers and drug targets for bladder cancer

Cao J., Chen S., Wang J. et al.

Nature Immunology, 2025

Identification of soluble biomarkers that associate with distinct manifestations of long COVID

Gao Y., Cai C., Adamo S. et al.

Scientific Reports, 2025

Profiling 92 circulating neurobiological proteins identifies novel candidate biomarkers of long-term cognitive outcome after ischemic stroke

Lagging C., Pedersen A., Petzold M. et al.

Investigational New Drugs, 2025

Safety, tolerability, and preliminary efficacy of nadunolimab, an anti-IL- 1 receptor accessory protein monoclonal antibody, in combination with pembrolizumab in patients with solid tumors

Cohen R., Jimeno A., Hreno J. et al.

Journal of Neurochemistry, 2025

IgD‐CD38‐B Cell Partially Mediates the Protective Effect of Higher Serum Triacylglycerol (53:4) Levels Against Parkinson's Disease

Jing Y., Zhu H., Yao P. et al.

4555 publications